High-risk scores are positively correlated with pro-tumor immune components (M0/M2 macrophages, activated mast cells, and neutrophils), while negatively associated with anti-tumor immune elements (activated DCs, M1 macrophages, resting mast cells, and memory CD4+/CD8+ T cells) [18, 19]. This evidence concerns the gene CD8A and neoplasm.